Oral AbstractsOA 17.06 Updated Analysis of KEYNOTE-024: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC With PD-L1 TPS ≥50%
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2017 Published by Elsevier Inc.